Ubs Asset Management Americas Inc Ligand Pharmaceuticals Inc Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 55,327 shares of LGND stock, worth $5.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,327
Previous 50,401
9.77%
Holding current value
$5.65 Million
Previous $5.4 Million
7.72%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding LGND
# of Institutions
280Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$293 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$210 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$105 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$92.6 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$76.1 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.73B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...